A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
Condition: Moderate-to-severe Allergic Asthma Interventions: Drug: Omalizumab; Drug: Placebo Sponsor: Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Asthma | Research | Sleep Disorders | Sleep Medicine | Sports Medicine | Study | Xolair